Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 12.11.2024
Xenetic Biosciences Мультипликаторы 2011-2024 | XBIO
Мультипликаторы по годам Xenetic Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.5 | -0.1 | -1.7 | -1.4 | -0.3 | -2.5 | -5.4 | -0.6 | -0.2 | -0.2 | - | - | - |
P/S |
2.4 | 0.3 | 8.4 | 34.2 | 252.4 | - | 2.5 | 11.7 | - | - | - | - | - |
EPS |
-2.7 | -4.6 | -0.6 | -1.7 | -6.3 | -9.7 | -0.4 | -7.8 | -3.0 | -0.1 | -0.1 | -0.1 | - |
EV (Enterprise Value) |
-2.14 млн | -11.5 млн | -7.06 млн | 4.36 млн | -1.73 млн | 22.5 млн | 18.6 млн | 35.7 млн | 13.1 млн | 5.82 млн | -4.17 млн | -10.7 млн | -16.9 млн |
EBITDA per Share |
-2.95 | -4.72 | -0.56 | -0.741 | -3.36 | -9.61 | -4.91 | -76.5 | -27.5 | -37.4 | - | - | - |
EV/EBITDA |
2.9 | -0.7 | 0.6 | -2.5 | -3.9 | -0.7 | -0.3 | 0.0 | - | - | - | ||
PEG |
-0.01 | -0.0 | 0.05 | -0.02 | -0.01 | 0.03 | -0.06 | 0.0 | 0.01 | 0.0 | - | - | - |
P/B |
0.6 | 0.0 | 0.5 | 1.2 | 0.3 | 1.9 | 1.3 | 2.2 | 0.4 | 0.2 | - | - | - |
P/CF |
-1.5 | -0.1 | -2.1 | -3.5 | -0.7 | -2.9 | 13.0 | -4.0 | -0.6 | -0.2 | - | - | - |
ROE % |
-42.21 | -48.01 | -30.69 | -89.18 | -74.22 | -73.65 | -25.14 | -335.24 | -189.26 | -136.51 | - | - | - |
ROA % |
-38.99 | -44.51 | -28.49 | -82.65 | -59.29 | -50.59 | -18.76 | -258.45 | -73.97 | -87.69 | - | - | - |
ROCE % |
-46.10 | -49.23 | -31.24 | -38.35 | -47.70 | -56.71 | -20.72 | -248.23 | -130.75 | -105.07 | - | - | - |
Current Ratio |
13.1 | 13.7 | 13.9 | 13.2 | 7.8 | 0.7 | 3.0 | 4.5 | 0.6 | 1.0 | - | - | - |
DSO |
- | - | - | - | - | - | - | 365.0 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | 1839.5 | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | -1839.5 | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Xenetic Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.28 | -0.83 | -0.78 | - | -0.69 | -0.69 | -0.56 | - | -0.56 | -1.9 | -0.12 | - | -0.13 | -0.13 | -0.15 | - | -1.2 | -0.15 | -0.19 | - | -2.67 | -1.56 | -6.45 | - | -2.31 | -2.78 | -0.21 | - | -0.26 | -0.34 | -0.34 | - | -0.28 | -6.12 | -0.78 | - | -1.26 | -0.27 | -0.02 | - | -0.02 | -0.02 | -0.03 | - | -0.02 | -0.01 | -0.01 | -0.001 | - | - | -0.01 | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | -0.59 | -1.91 | -0.12 | - | -0.14 | -0.13 | -0.16 | - | -1.67 | -0.16 | -0.2 | - | -2.32 | -1.56 | -1.64 | - | -2.31 | -2.73 | -0.21 | - | -0.26 | -0.33 | -0.33 | - | -0.25 | -5.54 | -0.4 | - | -0.89 | -0.31 | -0.01 | - | -0.02 | -0.02 | -0.02 | - | -0.02 | -0.01 | -0.01 | - | - | - | - | - | - | - | - |
ROE % |
-46.78 | -50.26 | -42.00 | -25.20 | -30.74 | -26.58 | -35.33 | -32.55 | -39.25 | -40.41 | -33.94 | -30.12 | -92.01 | -147.20 | -143.89 | -79.35 | -131.06 | -120.87 | -121.07 | -67.42 | -85.70 | -52.28 | -64.72 | -57.11 | -72.88 | -70.37 | -70.34 | -56.22 | -71.51 | -71.02 | -346.05 | -332.82 | -413.37 | -478.64 | -200.23 | -134.37 | -164.73 | -114.54 | -123.84 | -95.45 | -96.11 | -87.37 | -68.48 | -40.62 | -40.04 | 74.47 | 132.96 | 157.34 | 157.29 | 64.41 | 13.36 | -0.12 | - | - | - |
ROA % |
-41.08 | -44.47 | -38.62 | -23.31 | -28.48 | -24.81 | -32.80 | -30.25 | -36.60 | -37.78 | -31.69 | -27.93 | -85.29 | -136.31 | -133.41 | -73.55 | -114.86 | -98.80 | -97.95 | -53.86 | -66.42 | -37.67 | -45.32 | -39.23 | -51.00 | -50.21 | -51.40 | -41.96 | -53.74 | -53.76 | -266.29 | -256.58 | -288.07 | -307.77 | -86.65 | -52.52 | -72.02 | -60.04 | -70.29 | -61.31 | -61.74 | -56.25 | -44.16 | -26.33 | -25.96 | -38.57 | -48.38 | -45.43 | -45.37 | -18.75 | -4.12 | - | - | - | - |
ROCE % |
-50.20 | -53.63 | -45.76 | -27.73 | -33.57 | -28.88 | -36.48 | -33.10 | -39.93 | -40.91 | -34.55 | -30.67 | -116.66 | -195.83 | -192.54 | -104.11 | -156.09 | -122.07 | -122.03 | -67.69 | -86.00 | -52.33 | -64.44 | -56.86 | -72.53 | -69.89 | -70.08 | -55.94 | -69.86 | -68.12 | -315.38 | -292.94 | -350.45 | -394.04 | -147.04 | -107.89 | -137.55 | -109.70 | -114.32 | -83.08 | -83.69 | -74.08 | -57.08 | -39.83 | -39.27 | 63.13 | 109.66 | 131.15 | 131.10 | 48.75 | 10.41 | -0.10 | - | - | - |
Current Ratio |
8.0 | 5.7 | 13.1 | 13.1 | 11.2 | 14.6 | 16.0 | 13.7 | 14.8 | 12.9 | 16.9 | 13.9 | 19.0 | 11.3 | 14.4 | 13.7 | 13.7 | 13.7 | 13.7 | 5.0 | 5.0 | 5.0 | 5.0 | 3.2 | 3.2 | 3.2 | 3.2 | 3.9 | 3.9 | 3.9 | 3.9 | 4.4 | 4.4 | 4.4 | 4.4 | 1.6 | 1.6 | 1.6 | 1.6 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 5.5 | 0.8 | 0.8 | 0.8 | - | 1.0 | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10770.6 | 23.4 | 23.4 | 473.5 | 113.4 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 739.9 | 1215.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10770.6 | 23.4 | 23.4 | 473.5 | 113.4 | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -717.1 | -1215.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 10770.6 | 23.4 | 23.4 | 473.5 | 113.4 | - | - | - | - | - | - | - |
Все данные представлены в валюте USD